Qureight

Today we announce the appointment of Simon LF Walsh as our Chief Scientific Officer. Dr. Walsh is a recognised global expert in computer vision and lung disease with over 200 peer reviewed publications to his name. Dr Walsh said: "I’ve dedicated my career to developing tools that harness cutting edge machine learning research to improve treatment trial execution in interstitial lung diseases and other complex lung diseases. Joining Qureight in the CSO role allows me to apply my academic experience to drive forward innovation and, critically, implementation of the latest ML science." CEO Muhunthan Thillai said: "Welcoming Simon into Qureight’s senior leadership team is a pivotal moment in Qureight’s scale-up journey. His combination of thoracic imaging and machine learning skill experience places him in a unique position when it comes to clearly defining clinical problems and providing clinical oversight to the technical team working to solve these problems." See the video announcement here (and the link below): https://lnkd.in/djCxJQq2

🌟 Exciting News! 🌟 Please join us in welcoming Debbie Henthorn ⏩ to our team! 🎉 We’re thrilled to have her on board as Head of Scientific Operations. With a background in Science and Operations, we’re confident Debbie will be a great asset to our team as we continue to drive innovation and success. We're looking forward to the amazing things we’ll accomplish as a team this year. Welcome aboard, Debbie! 🚀👋 We're still hiring for several roles, if you're interested reach out!🥳

*No agencies please – any questions should be directed to l.evans@qureight.com* 🌟 We're Hiring! 🌟 Are you excited to take your career to new heights? We are looking for 2 more enthusiastic people to join our innovative team! We're looking for: 🔎 a Software Engineer 🔎 a DevOps Engineer If you're ready to make an impact in a start-up BioTech company, we want to hear from you! 📣 🔗 Apply here: Software Engineer - https://lnkd.in/e9U8qEFU DevOps Engineer - https://lnkd.in/eiUYrgTn #Hiring #CareerOpportunity #JoinUs #Qureight

*No agencies please – any questions should be directed to l.evans@qureight.com* 🌟 We're Hiring! 🌟 Are you excited to take your career to new heights? We are looking for a Clinical Project Manager to join our innovative team! If you're ready to make an impact in a start-up BioTech company, we want to hear from you! 📣 🔗 Apply here: https://lnkd.in/gZjjX8vS #Hiring #CareerOpportunity #JoinUs #Qureight

🎄✨ From our team to yours, we’d like to wish you a very Merry Christmas and a Happy New Year! 🎅🎉 As we reflect on the past year, we’re filled with gratitude for the connections and collaborations that have made it so special. Here's to new opportunities, growth, and exciting ventures in 2025! 🚀🎁 Wishing you joy, peace, and all the best as we step into the new year. 🥂 #HappyHolidays #MerryChristmas #CheersTo2025 #Qureight

Qureight has achieved ISO 27001 certification: the gold standard for data security in healthcare! 🔐 🎉 💡 Why it matters As healthcare technologies scale rapidly worldwide we need robust data security measures to protect patient privacy, maintain trust and develop our data curation capabilities. 🤝 What this means for our partners Qureight has the highest information security standards and can navigate complex global regulations. 🔎 Data security in clinical trials It reduces blockers to innovation in AI and ML and accelerates our ability to create cutting-edge treatments for idiopathic pulmonary fibrosis (IPF), pulmonary hypertension, and lung cancer. Achieving ISO 27001 certification is a significant step forward for us and we’re thrilled! 🎉 Learn more about this milestone and what it means for healthcare and clinical trials in our latest blog ➡️ https://lnkd.in/eigJWwkU

Thanks to Guinness Ventures for asking me to speak at their London breakfast event this morning on our journey to date with Qureight. The early train down from Cambridge meant I definitely needed the ☕ - I wasn't quite as sleepy as I looked! Their entire team have been really supportive since their investment a few months ago and it is a real pleasure working with Joe Staunton as we build our company with backing from George Whear Malcolm King and more recently Lisa Fox. #techbio

🚨BTS WINTER MEETING 2024🚨 We're thrilled to share that Dr. Hakim Ghani be presenting at the British Thoracic Society (BTS) Winter Meeting 2024 in London, where he'll be diving into an exciting and emerging topic in pulmonary vascular disease, showing how Qureight's models of pulmonary blood volumes could improve the treatment of Pulmonary Hypertension patients.  ✉️ Save the date: November 27-29, 2024, at the QEII Centre, Westminster.  🔬 Title: Quantitative Assessment of Pulmonary Artery Blood Volume in Chronic Thromboembolic Pulmonary Hypertension: Using CTPA and Machine Learning 🗣️ Session: "Crime and Punishment" in Pulmonary Vascular Disease 📅 Date: November 27, 2024 ⏰ Time: 10:45 AM 📍 Room: Rutherford, 4th Floor   Dr Ghani will be focusing on the clinical application of automated CTPA (Contrast-Enhanced CT Pulmonary Angiography) and how machine learning can provide a quantitative, accurate assessment of pulmonary vascular blood volumes. This method has the potential to revolutionize the way we approach chronic thromboembolic pulmonary hypertension (CTEPH) by providing more timely, precise, and reproducible data, allowing for better patient outcomes and treatment strategies. We're looking forward to connecting with experts, researchers, and clinicians to discuss these exciting advancements in pulmonary vascular disease! #BTSWinter2024 #CTEPH #PulmonaryHypertension #MachineLearning #MedicalInnovation #PulmonaryVascularDisease #CTPA #Healthcare #MedicalResearch #Qureight https://lnkd.in/eDASr_ud

Join us for 'Life in AI & MedTech Startups: What I Wished I Knew at the Beginning' with Dr Steven Bishop 🚀🚀🙌🏽 🗓 Date: 2nd December 2024 🕕 Time: 6:00 PM 📍 Location: Cavonius Centre, Stephen Hawking Building, Gonville & Caius College, Cambridge Dr Bishop, the Chief Data Officer at Qureight and a Cambridge alum in computer science and medicine, will share his insights and lessons learned from a career in AI and MedTech. With over 5 years of NHS experience and various senior roles in leading MedTech companies, Dr Bishop's talk is perfect for those interested in AI in healthcare 💯🩻

We’ve been chosen as one of a few selected Cambridge-based companies to present at today’s Investing in Cambridge event, hosted at Wellcome Collection, and we’re delighted!  Our CEO and Co-Founder, Muhunthan Thillai, is looking forward to presenting… 🌐How our #AI stack analyses extremely complex data including clinical trial images, physiological data and blood biomarkers at once. ⚕️The major industry partnerships allowing us to access real-world data for lung and heart disease.  💪How our cloud-based #ML models are tackling healthcare problems like interstitial lung diseases, pulmonary hypertension and lung cancer. See you there!  https://lnkd.in/ezsmtdA9